Premium
EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy
Author(s) -
Helen Dolk,
de Lolkje Jong-van den Berg,
Anna Pierini,
Joan K. Morris,
Marian K. Bakker,
Sue Jordan,
Ester Garne,
Kari Klungsøyr,
Maria Loane,
Rachel Charlton,
Michiel Luteijn,
Marlene Sinclair,
Anna Latos Bielenska,
EUROmediCAT Steering
Publication year - 2015
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.3866
Subject(s) - pharmacovigilance , medicine , pharmacoepidemiology , pregnancy , environmental health , pharmacology , adverse effect , biology , medical prescription , genetics
EUROmediCAT Steering Group: Helen Dolk (Ulster University, United Kingdom), Lolkje de Jong-van den Berg (Groningen University, The Netherlands), Anna Pierini (Institute of Clinical Pysiology-National Research Council, Pisa, Italy), Joan Morris (Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom), Marian Bakker (University Medical Center Groning, The Netherlands), Sue Jordan (Swansea University, United Kingdon), Ester Garne (Hospital Lillebaelt, Denmark), Kari Klungsoyr (University of Bergen, Norway), Maria Loane (Ulster University, United Kingdom), Rachel Charlton (University of Bath, United Kingdom), Michiel Luteijn (Ulster University, United Kingdom), Marlene Sinclair (Ulster University, United Kingdom), Anna Latos Bielenska (Poznan University of Medical Sciences, Poland).